MONISTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Monistat, and when can generic versions of Monistat launch?
Monistat is a drug marketed by Janssen Pharma, Medtech Products, Personal Prods, and Insight Pharms. and is included in twelve NDAs.
The generic ingredient in MONISTAT is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Monistat
A generic version of MONISTAT was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MONISTAT?
- What are the global sales for MONISTAT?
- What is Average Wholesale Price for MONISTAT?
Summary for MONISTAT
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 1 |
Patent Applications: | 4,861 |
DailyMed Link: | MONISTAT at DailyMed |
Recent Clinical Trials for MONISTAT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Universidad Autonoma de San Luis Potosà | Phase 4 |
Hospital Central "Dr. Ignacio Morones Prieto" | Phase 4 |
US Patents and Regulatory Information for MONISTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharma | MONISTAT | miconazole | INJECTABLE;INJECTION | 018040-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Medtech Products | MONISTAT 3 COMBINATION PACK (PREFILLED) | miconazole nitrate | CREAM;TOPICAL, VAGINAL | 021261-001 | Feb 2, 2001 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Medtech Products | MONISTAT 3 | miconazole nitrate | SUPPOSITORY;VAGINAL | 018888-001 | Aug 15, 1984 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MONISTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharma | MONISTAT | miconazole | INJECTABLE;INJECTION | 018040-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharma | MONISTAT | miconazole | INJECTABLE;INJECTION | 018040-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MONISTAT
See the table below for patents covering MONISTAT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Czechoslovakia | 184771 | METHOD FOR PRODUCING IMIDAZOLE DERIVATIVES | ⤷ Sign Up |
Japan | S5039664 | ⤷ Sign Up | |
United Kingdom | 1244530 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |